- AI
- Molecular Imaging
- CT
- X-Ray
- Ultrasound
- MRI
- Facility Management
- Mammography
Hitachi offers high-field open
Hitachi Medical Systems formally launched its 1.2T vertical field open MR scanner at the RSNA meeting. Oasis, shown as a work-in-progress at last year’s meeting, cleared the FDA in September.
Hitachi Medical Systems formally launched its 1.2T vertical field open MR scanner at the RSNA meeting. Oasis, shown as a work-in-progress at last year's meeting, cleared the FDA in September. Built around a gradient system with 33 mT/m amplitude and 100 T/m/sec slew rate, the scanner features Zenith RF coils. These coils are the culmination of 20 years' experience in the development of vertical field MR, according to Hitachi. Field uniformity is driven by the company's proprietary Higher-Order Active Shim Technology, which is designed to ensure fat saturation over the scanner's large field-of-view. Oasis also features Hitachi's RAPID parallel imaging, TRAQ time-resolved MR angiography, and RADAR patient-motion compensating technology.
Hitachi is also unveiling a new pulse sequence for the cylindrical 1.5T Echelon scanner. The TIGRE sequence supports dynamic abdominal and bilateral breast studies at high temporal and spatial resolution.
European Society of Breast Imaging Issues Updated Breast Cancer Screening Recommendations
April 24th 2024One of the recommendations from the European Society of Breast Imaging (EUSOBI) is annual breast MRI exams starting at 25 years of age for women deemed to be at high risk for breast cancer.
New Literature Review Assesses Merits of Cardiac MRI After Survival of Sudden Cardiac Arrest
April 19th 2024While noting inconsistencies with the diagnostic yield of cardiac MRI in patients who survived sudden cardiac arrest, researchers cited unique advantages in characterizing ischemic cardiomyopathy (ICM) and facilitating alternate diagnoses.
Study of Ofatumumab for Multiple Sclerosis Shows 'Profoundly Suppressed MRI Lesion Activity'
April 17th 2024The use of continuous ofatumumab in patients within three years of a relapsing multiple sclerosis diagnosis led to substantial reductions in associated lesions on brain MRI scans, according to research recently presented at the American Academy of Neurology (AAN) conference.
